Literature DB >> 20088760

Targeting tumor lymphangiogenesis: an update.

M Raica1, D Ribatti.   

Abstract

Various human tumors preferentially metastasize by lymphatic route and lymphovascular invasion predicts lymph node metastasis. In this review article, we will summarize recent literature data concerning lymphangiogenesis, focusing on tumor lymphangiogenesis. In detail, we try to answer some important questions related to: a) The specificity of lymphatic endothelial cell markers; b) The differential characteristics of lymphatic vessels in tumors; c) The interplay between different lymphangiogenic factors; d) The role of pre-existing and newly-formed lymphatic vessels in tumors and their proliferative potential; e) The role of lymphatic vessels in tumor metastases; e) The prognostic significance of lymphatic microvascular density in tumors; f) The inhibition of lymphangiogenesis in tumors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20088760     DOI: 10.2174/092986710790514471

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  12 in total

Review 1.  Molecular mechanisms of lymphatic metastasis in solid tumors of the gastrointestinal tract.

Authors:  Melanie C Langheinrich; Vera Schellerer; Aristotelis Perrakis; Clemens Lohmüller; Claus Schildberg; Elisabeth Naschberger; Michael Stürzl; Werner Hohenberger; Roland S Croner
Journal:  Int J Clin Exp Pathol       Date:  2012-09-05

2.  Rapamycin inhibits lymphatic endothelial cell tube formation by downregulating vascular endothelial growth factor receptor 3 protein expression.

Authors:  Yan Luo; Lei Liu; Donna Rogers; Wei Su; Yoshinobu Odaka; Hongyu Zhou; Wenxing Chen; Tao Shen; J Steven Alexander; Shile Huang
Journal:  Neoplasia       Date:  2012-03       Impact factor: 5.715

Review 3.  Molecular background of the regional lymph node metastasis of gastric cancer.

Authors:  Tong Zhu; Xueqian Hu; Pinkang Wei; Guangzhi Shan
Journal:  Oncol Lett       Date:  2018-01-16       Impact factor: 2.967

4.  Lymphangiogenesis in non-Hodgkin's lymphoma and its correlation with cyclooxygenase-2 and vascular endothelial growth factor-C.

Authors:  Shu-Pei Ma; Mei Lin; Hai-Ning Liu; Jian-Xian Yu
Journal:  Oncol Lett       Date:  2012-07-23       Impact factor: 2.967

5.  Digging deeper into lymphatic vessel formation in vitro and in vivo.

Authors:  Benoit Detry; Françoise Bruyère; Charlotte Erpicum; Jenny Paupert; Françoise Lamaye; Catherine Maillard; Bénédicte Lenoir; Jean-Michel Foidart; Marc Thiry; Agnès Noël
Journal:  BMC Cell Biol       Date:  2011-06-24       Impact factor: 4.241

6.  A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.

Authors:  Xin-Ping Li; Wei Jing; Jian-Jun Sun; Zhong-Yan Liu; Jing-Tao Zhang; Wei Sun; Wei Zhu; Yue-Zu Fan
Journal:  BMC Cancer       Date:  2015-07-19       Impact factor: 4.430

7.  Lymphatic endothelial cells support tumor growth in breast cancer.

Authors:  Esak Lee; Niranjan B Pandey; Aleksander S Popel
Journal:  Sci Rep       Date:  2014-07-28       Impact factor: 4.379

Review 8.  Cancer stem cells and tumor metastasis (Review).

Authors:  Shuang Li; Qin Li
Journal:  Int J Oncol       Date:  2014-04-02       Impact factor: 5.650

9.  BRG1 targeting STAT3/VEGFC signaling regulates lymphangiogenesis in colorectal cancer.

Authors:  Xu Zhu; Li Sun; Jingqin Lan; Linli Xu; Meng Zhang; Xuelai Luo; Jianping Gong; Guihua Wang; Xianglin Yuan; Junbo Hu; Jing Wang
Journal:  Oncotarget       Date:  2016-06-14

10.  The prognostic significance of tumor lymphangiogenesis and lymphatic vessel density in endometrioid carcinoma of the uterine corpus.

Authors:  Mika Sakaki; Masanori Yasuda; Mitsutake Yano; Yoshiya Goto; Masaru Nakamura; Hidekazu Kayano; Kosei Hasegawa
Journal:  Oncol Lett       Date:  2017-09-04       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.